Skip to content

Robert W. Pollock, MD

NPI 1538148572ActiveIndividual· Pathology, Clinical Pathology· Orlando, FL

Pathology, Clinical Pathology (MD) in Orlando, Florida, licensed in FL, with an NPI issued in January 2006. Part D covered 16 prescriptions written in 2024, 100% of them generic. Takeda Pharmaceuticals U.S.A., Inc. reported $44,032 in payments in 2025, mostly consulting fees.

Overview

NPI1538148572
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJan 10, 2006
Last updated in NPPESOct 22, 2007

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)16 · 28 30-day fills
Total drug cost$290.60
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$44,032 · 23 payments from 1 company
  • 2024$34,888 · 34 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Takeda Pharmaceuticals U.S.A., Inc.$44,03223

What the 2025 payments were for

  • Consulting Fee$43,557 · 21 payments
  • Travel and Lodging$475.70 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pathology, Clinical Pathology providers in Orlando

All Pathology, Clinical Pathology providers in Florida